Compound information
- Natural Products
- ZC2145843
- Molecular Formula
- C18H26ClN3O
- Molecular Weight
- 335.176440132 g/mol
- Structure
-
- IUPAC Name
- [4-(5-chloro-2-methyl-phenyl)piperazin-1-yl]-(4-methyl-1-piperidyl)methanone
- InChI
- InChI=1S/C18H26ClN3O/c1-14-5-7-21(8-6-14)18(23)22-11-9-20(10-12-22)17-13-16(19)4-3-15(17)2/h3-4,13-14H,5-12H2,1-2H3
- InChI Key
- XZTXVAGEMXRLSI-UHFFFAOYSA-N
- SMILES
- Cc1ccc(Cl)cc1N1CCN(C(=O)N2CCC(C)CC2)CC1
- Source
- ZINC000007504452
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 3 |
Heteroatom Count | 5 | Rotatable Bond Count | 1 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 26.79 Å2 | LogP | 4.037 |
LogS | -4.131 | LogD | 3.799 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.168 | Pgp substrate | 0.252 |
HIA | 0.973 | F20 % | 0.993 |
F30 % | 0.535 | Caco-2 | -4.454 |
MDCK | -5.013 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.018 | PPB | 91.974 |
VD | 0.43 | Fu | 1.596 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.022 | CYP1A2 substrate | 0.611 |
CYP2A6 substrate | 0.374 | CYP2B6 substrate | 0.672 |
CYP2C19 inhibitor | 0.926 | CYP2C19 substrate | 0.75 |
CYP2C8 substrate | 0.657 | CYP2C9 inhibitor | 0.646 |
CYP2C9 substrate | 0.93 | CYP2D6 inhibitor | 0.162 |
CYP2D6 substrate | 0.933 | CYP2E1 substrate | 0.773 |
CYP3A4 inhibitor | 0.176 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.173 | CL | 2.893 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.923 | Hepatotoxicity | 0.978 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.857 |
FDAMDD | 0.587 | Skin Sensitization | 0.311 |
Carcinogenicity | 0.859 | Eye Corrosion | 0.021 |
Eye Irritation | 0.12 | Respiratory Toxicity | 0.174 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.888 | IGC50 | 3.554 |
LC50FM | -3.092 | LC50DM | -3.827 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.56 | NR-AR-LBD | 0.187 |
NR-AhR | 0.14 | NR-Aromatase | 0.137 |
NR-ER | 0.325 | NR-ER-LBD | 0.351 |
NR-PPAR-gamma | 0.158 | SR-ARE | 0.745 |
SR-ATAD5 | 0.305 | SR-HSE | 0.271 |
SR-MMP | 0.011 | SR-p53 | 0.069 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.